Johnson & Johnson (JNJ) Tops Q1 EPS by 2c; Updates FY16 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. LEN
7. NVDA
8. USO
9. LMT
10. AMZN

Go back to Johnson & Johnson (JNJ) Tops Q1 EPS by 2c; Updates FY16 Outlook

Piper Jaffray Raises Price Target on Johnson & Johnson (JNJ) Following 1Q Report

April 20, 2016 7:42 AM EDT

Piper Jaffray reiterated a Neutral rating on Johnson & Johnson (NYSE: JNJ), and raised the price target to $106.00 (from $105.00), following the company's 1Q earnings report. In Pharma, total sales of $8.2B and key drug sales were slightly better than estimates. The Medical Device segment generated revenue of $6.11B,... More